# Scribe Therapeutics

**Canonical:** https://apis.io/providers/scribe-therapeutics/  
**Website:** https://www.scribetx.com/  
**APIs profiled:** 0

Scribe Therapeutics is a clinical-stage biotechnology company founded in 2018 and headquartered in Alameda, California, engineering CRISPR-based genetic medicines through its proprietary "CRISPR by Design" platform. Co-founded by molecular engineers Benjamin Oakes, Brett Staahl, and David Savage alongside CRISPR co-inventor Jennifer Doudna, the company builds highly engineered CasX-derived enzymes — including its X-Editing (XE) molecules for precise gene editing and ELXR epigenetic long-term X-repressor technology for durable gene silencing without altering the underlying DNA sequence. Scribe focuses initially on cardiometabolic disease, the leading cause of death globally, and expands into areas such as sickle cell disease and neurological conditions through strategic pharmaceutical partnerships. The company is backed by a16z and Menlo Ventures and was surfaced to the API Evangelist network as a venture portfolio company. Scribe Therapeutics is a therapeutics and drug-discovery company and does not currently publish a public developer API, SDK, or documented API surface.

## Kin Score — 7.6 / 100 (minimal)

Scored 2026-08-21 under rubric 0.12.0. Trend: flat (+0.0 from 7.6).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Scribe Therapeutics Domain Security** — TLSv1.3 · HSTS · DNSSEC · DMARC

## Tags

Company, Biotechnology, CRISPR, Gene Editing, Genetic Medicine, Therapeutics, Life Sciences, Drug Discovery

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/scribe-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.